Kagnoff M F, Harwood J I, Bugawan T L, Erlich H A
Department of Medicine, University of California at San Diego, La Jolla 92093.
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6274-8. doi: 10.1073/pnas.86.16.6274.
Celiac disease is strongly associated with the HLA class II D-region serologic markers DR3 (DRw17) and DQw2. Moreover, by restriction fragment length polymorphism analysis, greater than 90% of DR3 (DRw17), DQw2 celiac disease patients have a polymorphic 4.0-kilobase Rsa I DP B gene DNA fragment. The present study sought to determine if there is a unique HLA class II D-region A or B gene structural variant on the DR3 (DRw17) haplotype found in celiac disease. The polymorphic second exons of the coding DRB, DQA and DQB, and DPA and DPB genes in celiac disease patients with the DR3 (DRw17) haplotype were sequenced after amplification by the polymerase chain reaction. To define the DP B genes associated with celiac disease, the second exons of the coding DP B genes from 27 celiac disease patients were amplified similarly and probed by using a panel of sequence specific oligonucleotides. The HLA-DR, -DQ, and -DP A and B gene second exon sequences of celiac disease patients were noted to be identical to sequences that can be found also, although at a significantly lower frequency, in unaffected individuals. This is compatible with a disease model wherein the HLA class II genes on the DR3 (DRw17) haplotype are necessary, but not sufficient, for the phenotypic expression of celiac disease. Analysis of the DP B genes revealed a significant increase in the frequency of the alleles DPB1 and DPB3 in celiac disease. Furthermore, the increased frequency of the 4.0-kilobase Rsa I DP B gene restriction fragment length polymorphism in celiac disease can be accounted for by the overrepresentation in disease of the alleles DPB1 and DPB3. The HLA-associated susceptibility to celiac disease appears to be multigenic, with specific, but structurally normal, allelic variants in the DP and DQ/DR subregions contributing to disease susceptibility.
乳糜泻与人类白细胞抗原(HLA)II类D区血清学标志物DR3(DRw17)和DQw2密切相关。此外,通过限制性片段长度多态性分析,超过90%的DR3(DRw17)、DQw2乳糜泻患者有一个多态性的4.0千碱基Rsa I DP B基因DNA片段。本研究旨在确定在乳糜泻中发现的DR3(DRw17)单倍型上是否存在独特的HLA II类D区A或B基因结构变异。对具有DR3(DRw17)单倍型的乳糜泻患者编码DRB、DQA和DQB以及DPA和DPB基因的多态性第二外显子进行聚合酶链反应扩增后测序。为了确定与乳糜泻相关的DP B基因,对27例乳糜泻患者编码DP B基因的第二外显子进行类似扩增,并使用一组序列特异性寡核苷酸进行探针检测。乳糜泻患者的HLA-DR、-DQ和-DP A和B基因第二外显子序列被发现与在未受影响个体中也能发现的序列相同,尽管频率显著较低。这与一种疾病模型相符,即DR3(DRw17)单倍型上的HLA II类基因对于乳糜泻的表型表达是必要的,但不是充分的。对DP B基因的分析显示,乳糜泻中DPB1和DPB3等位基因的频率显著增加。此外,乳糜泻中4.0千碱基Rsa I DP B基因限制性片段长度多态性频率的增加可归因于DPB1和DPB3等位基因在疾病中的过度表达。HLA相关的乳糜泻易感性似乎是多基因的,DP和DQ/DR亚区域中特定但结构正常的等位基因变异导致疾病易感性。